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Male F-344 rats were given [3H]aflatoxin B, (AFBj) in the
drinking water at three exposure levels (0.02, 0.6, 20 /*g/l,
resulting in average dose levels of 2.2, 73, 2110 ng/kg per
day). After 4, 6 and 8 weeks, DNA was isolated from the livers
and analyzed for aflatoxin-DNA adducts. The level of DNA
adducts did not increase significantly after 4 weeks, indicating
that a steady-state for adduct formation and removal had
nearly been reached. At 8 weeks, the adduct levels were 0.91,
32 and 850 nucleotide-aflatoxin adducts per 109 nucieotides,
i.e. clearly proportional to the dose. At the high dose level,
a near 50% tumor incidence would be expected in a 2-year
bioassay with F-344 rats while the low dose used is within
the range of estimated human dietary exposures to aflatoxin
in Western countries. The proportionality seen between
exposure and steady-state DNA adduct level is discussed with
respect to a linear extrapolation of the tumor risk to low dose.
Introduction
Covalent binding to DNA is an activity common to a large
number of chemical carcinogens (1). With the use of radiolabeled
carcinogen, DNA adducts are detectable at dose levels that are
much lower than those required for a statistically significant
increase in tumor incidence in an animal bioassay for carcino-
genicity. The shape of the dose—response curve for DNA adduct
formation is therefore considered useful information for a
biologically based risk extrapolation (2).
Aflatoxins comprise a group of fungal metabolites of which
aflatoxin B, (AFB,*) is among the most potent carcinogens
found in food (3). A relationship between mycotoxin exposure
and human liver cancer incidence is suggested by dose-dependent
correlations of exposure to aflatoxins and cancer incidence rates
in some areas of Africa and Asia (4). While doses of up to
220 ng/kg body wt/day have been reported in these countries,
daily exposure to aflatoxin in the USA is estimated to be between
0.25 ng/kg (5) and 3 ng/kg (6).
The mechanism of action of AFB, involves enzymatic
oxidation to an epoxide and subsequent covalent binding to DNA,
predominantly at the nitrogen-7 of guanine (7,8). The rates of
the processes that govern formation and removal of carcinogen -
DNA adducts, e.g. diffusion, chemical and enzymatic reactions,
are expected to be proportional to the concentration in the low
dose range. Proportionality between exposure dose and DNA
adduct level has indeed been reported with single doses of AFBj
(9). With chronic exposure, the level of DNA adduct is a result
of continuous formation and removal, and it is the steady-state
DNA damage reached after some time that probably determines
•Abbreviations: AFB,, aflatoxin B,.
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the lifetime risk of cancer. The data available so far are derived
from AFB] dose levels that would significantly increase tumor
incidence (10—12). They do not provide information for low-dose
risk extrapolation. In this report, the dose—response relationship
for the steady-state level of DNA adducts reached in rat liver
DNA at levels of human exposure to AFB, is analysed.
Materials and methods
Materials
[3H]AFB, (1 mCi/ml in ethanol) was from Moravek Biocherrucals, City of
Industry, CA. The radiochemical purity was determined by TLC on silica-gel
plates developed with chloroform/acetone, 9:1. Unlabeled AFBj was from Senn
Chemicals, Dielsdorf, Switzerland. Male F-344 rats [CDF(F-344)/CrlBR] were
from Charles River Wiga, Sulzfeld, FRG.
The radiochemical purity of [3H]AFB, decreased from >98% to 70% within
1 week at room temperature in the presence of water. Therefore, the application
solutions used for experiments I and II were kept at 4°C and were freshly prepared
after 5 days. For experiment ID, the drinking water was replaced twice weekly.
DNA binding in rat liver
Experiment I. DNA repair. [3H]AFB| (batch with a sp. act. of 8 Ci/mmol,
radiochemical purity >98%) was diluted with distilled water to a chemical
concentration of 100 ng/2 ml. Rats (wt range 221 -264 g) were given 2 ml/kg
by oral gavage (100 ng/kg) once or 10 times at daily intervals. Groups of two
rats were killed 24 h, 3, 7 or 11 days after the last administration and DNA was
isolated from the livers according to Sagelsdorff et al. (13) The sp. act. of the
DNA was determined by spectrophotometry (1 mg/ml = 20 A26O „„) and liquid
scintillation counting. Enzymatic hydrolysis of the DNA to the 3'-nucieotides
and separation of the aflatoxin—nucleotide adducts from normal nucieotides by
reverse-phase HPLC in a phosphate buffer -methanol gradient was performed
according to Sagelsdorff et al. (14).
Experiment II: DNA adduct level as a function of oral dose. [3H]AFB, (batch
8 Ci/mmol) was administered by oral gavage (once or 10 times at daily intervals)
at six dose levels, spanning five orders of magnitude from 1 ng/kg to 100 /ig/kg.
The body wts of the rats ranged between 182 and 220 g. Application solutions
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Fig. 1. Aflatoxin-DNA adduct levels in the liver of male F-344 rats, at
various times after oral gavage of a single dose or of 10 daily doses of
100 ng/kg tritiated AFB,. Semi-log plot. Two rats per group; one symbol
shown when individual difference is smaller than the symbol size.
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for dose levels 1, 10 and 100 ng/kg were prepared by appropriate dilution of
the stock solution with distilled water (see experiment I). For dose levels 1, 10
and 100 /ig/kg, unlabeled AFB, in ethanol was used instead of water. Previous
experiments have shown that the DNA-binding potency of AFB , is not affected
by pretreatment for 10 days at 4% (w/v) ethanol in the drinking water or by
simultaneous oral administration of up to 4 g/kg ethanol (15). DNA was isolated
from the livers 24 h after the last dose and analysed for adducts as described above.
Experiment III. DNA adduct level after chronic exposure in the drinking water.
[3H]AFB| (batch 20 Ci/mmol) was administered in the drinking water for 4,
6 and 8 weeks at three dose levels to groups of three animals. The drinking
water contained 2840 d.p.m./ml as AFB, at all dose levels. The chemical
concentrations of AFB| (20 ng/1, 600 ng/1 and 20 /ig/1) were adjusted by
appropriate addition of unlabeled AFB, to the intermediate and the high dose
levels. The animal wts ranged between 113 and 159 g (mean = 135 g) at the
beginning of the dosing and were 210-264 (mean = 245 g), 246-295 (mean
= 273 g) and 279-305 (mean = 294 g) at 28, 43 and 56 days respectively.
The weight gain was not different between the groups. The individual dose was
calculated on the basis of the water consumption (range 16-22 ml/rat/day) and
was averaged over the entire treatment period. Averaged over all animals in the
56 day group, dose levels of 2.2, 73, 2110 ng/kg/day resulted. At the end of
the exposure period the animals were killed and liver DNA was analysed as
described above (experiment I).
Results
DNA radioactivity
Nucleotide analyses showed that the normal nucleotides were not
radiolabeled. All radioactivity eluted without detectable optical
density, nearly all of it at elution times known for the lipophilic
aflatoxin —nucleotide adducts (16). The sp. act. of the DNA
samples was therefore converted to adduct levels on the basis
of the sp. act. of the [3H]AFB) used and of an average mol. wt
of 309 daltons for a DNA nucleotide.
DNA repair
The rate of removal of DNA adducts was investigated in
order to define appropriate periods of exposure to reach near
steady-state conditions for the level of DNA adducts. Figure 1
shows a semi-log plot of the level of DNA adducts measured
in the liver at 1, 3, 7 and 11 days after one single oral dose of
100 ng/kg tritiated AFB, to male F-344 rats (1 X p.o.), and
after the last of 10 oral doses given at daily intervals (10X p.o.).
The loss of DNA adducts was faster initially. Later, the adducts
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Fig. 2. Aflatoxin-DNA adduct levels in male F-344 rat liver, as a function
of dose (jr-axis) and after different periods of exposure (different curves) to
[3H]AFB,. Double-log plot. Solid lines connecting three and more points
are linear regressions. DW, administration in the drinking water. Standard
deviations seen only if larger than the symbol size.
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disappeared only slowly, with a half-life of 2 —3 weeks. Under
the assumption that all processes follow first-order kinetics and
following general pharmacokinetic principles, a theoretical value
of 93.75% of the limiting (steady-state) adduct value would have
to be reached after four elimination half-lives. On the basis of
the repair rates determined above, a near steady-state level of
DNA adducts is therefore expected to be reached within ~8
weeks.
Nucleotide analyses were consistent with reports in the
literature (16,17): the initially formed, late-eluting adduct
(putatively assigned to be the AFB,-guanyl-7 adduct) disappears
relatively rapidly, by repair and by chemical modifications;
opening of the imidazole ring of guanine results in adducts that
appear to be more refractory to DNA repair (16,17).
DNA adduct levels as a function of dose and period of exposure
The levels of DNA adducts are shown in Figure 2 as a function
of dose (x-axis). The different curves illustrate that DNA adducts
accumulate with increasing periods of exposure, l x — 10 x
— 28 days — 43 days — 56 days of treatment. The increase
is no longer significant, however, between 28 and 43 days or
between 43 and 56 days. This indicates that near steady-state had
been reached, as predicted on the basis of the half-lives of
the adducts. At 8 weeks, the adduct levels averaged 0.91 ± 0.19,
32 ± 4 and 850 ± 11 aflatoxin-nucleotide adducts/109
nucleotides, at the three dose levels—2.2, 73, 2110 ng/kg/day.
The accumulation of adducts with time was substantial: 24 h
after a 10-day treatment, the adduct level was 6 times higher than
24 h after a single administration. After 56 days of continuous
exposure, the adduct level was 16 times the single-dose value.
The level of DNA adducts was proportional to dose under all
treatment conditions. At 8 weeks, for instance, the adduct levels
were in a ratio of 1:35:934, while the dose levels were in
1:33:959. Proportionality is also illustrated in the double-log plot
of Figure 2 by the slope of 1.0 for all regression lines. Two
high-dose data points did not follow this rule: (i) after 10 oral
doses of 100 /tg/kg/day, the DNA adduct level was no longer
proportional to the dose. This could be due to a saturation of
the enzymatic activation of AFB) at this highest dose level, (ii)
The value seen with the 28 day high-dose treatment is also
too low. This result was due to one animal that showed an
unexplained low adduct value.
Discussion
Our data show that the level of aflatoxin —DNA adducts in rat
liver is proportional to dose under all exposure conditions used.
The investigated dose range covered five orders of magnitude
and included both tumorigenic dose levels and levels of dietary
human exposure.
The high dose level used in the drinking water experiment
(2.1 /ig/kg/day) would have resulted in a significant increase in
liver tumors in male F-344 rats. A 50 p.p.b. AFBi diet for 1
year (approximate daily dose 2.5 /tg/kg) gave rise to a 40%
incidence of hepatocellular carcinoma within 2 years (18). It is
tempting, therefore, to relate the level of the steady-state DNA
damage to a tumor incidence observed after long-term treatment,
and to investigate the question of whether the data can be
extrapolated to other species. The 56 day cumulative DNA
damage at this dose level was 850 adducts/109 nucleotides in rat
liver DNA. Dashwood and co-workers (19) have found in the
trout that an adduct level of 1040/109 nucleotides after 2 weeks
resulted in a 50% liver tumor incidence within 1 year. In humans,
preliminary data on DNA adduct levels are also available. In liver
Dose-response relationship for AFB,-DNA adducts
samples from patients undergoing surgery for liver cancer in
Taiwan, aflatoxin—DNA adducts were determined with immuno-
logical techniques. Adduct levels in the range 1200-1700 per
1$ nucleotides were found in normal liver tissue (20). These
values are of the same order as those seen in rats and trout at
high tumor risk. Eventually, comparisons between experimental
and human data can be made on the basis of adduct data.
Proportionality between exposure dose and DNA adduct
levels has been shown here but the question remains whether
proportionality also holds between DNA damage and tumor
incidence. This hypothesis cannot be answered experimentally
in the low dose range. In the high dose range, the correlation
of hepatic tumor incidence in the trout with the level of
aflatoxin—DNA adducts does not appear to deviate from linearity
(21). The combined data therefore support the idea that a linear
extrapolation of the tumor risk to low dose is appropriate for
the induction of liver tumors by AFB|.
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